Pharmaceutical - Antibiotics and Infectious diseases


Popular Filters

126 to 150 of 212 results

GlaxoSmithKline and Abbott to start production in Ukraine


UK pharma giant GlaxoSmithKline (LSE: GSK) and the USA's Abbott (NYSE: ABT) are considering launching…

Anti-viralsAntibiotics and Infectious diseasesEuropeGlaxoSmithKlineIndarPharmaceuticalProductionVaccines

Sinclair IS in Flammacerium deal with Hikma; sells Fazol G to Majorelle


UK specialty pharma firm Sinclair IS Pharma (AIM: SPH.L) and Jordon-headquartered Hikma Pharmaceuticals…

Antibiotics and Infectious diseasesFazol GHikma PharmaceuticalsLaboratoires MajorelleLicensingPharmaceuticalSinclair IS PharmaWomen's Health

BioAlliance Pharma pursues development plan for Loramyc in Japan through partner Sosei


French orphan oncology and supportive care specialist BioAlliance Pharma (Euronext Paris: BIO) says its…

Antibiotics and Infectious diseasesAsia-PacificBioAlliance PharmaLoramycOravigPharmaceuticalRegulationResearchSosei

Merck & Co gets all clear to continue Vytorin study; FDA warns on Pfizer's Zithromax


US pharma giant Merck & Co said yesterday that the Data Safety Monitoring Board (DSMB) of the IMPROVE-IT…

Antibiotics and Infectious diseasesCardio-vascularMerck & CoNorth AmericaPfizerPharmaceuticalRegulationResearchVytorinZithromax

Clinigen and Theravance deal on Vibativ; Cubist expands rights to ceftolozane


UK-based Clinigen Group (LSE: CLIN ) and Theravance (Nasdaq: THRX) of the USA have entered into an exclusive…

Antibiotics and Infectious diseasesAstellas PharmaceftolozaneClinigen GroupCubist PharmaceuticalsEuropeGlobalLicensingPharmaceuticalTheravanceVibativ

Antimicrobial resistance poses "catastrophic threat," says UK's Chief Medical Officer


Global action is needed to tackle the catastrophic threat of antimicrobial resistance, which in 20 years…

Antibiotics and Infectious diseasesEuropeHealthcarePharmaceuticalResearch

Riboxx Pharma links with China National Biotec to evaluate Riboxxim as adjuvant in a vaccine


Germany's Riboxx Pharmaceuticals GmbH and China National Biotec Group (CNBG) say they have initiated…

Antibiotics and Infectious diseasesChina National BiotecPharmaceuticalResearchRiboxx PharmaceuticalsRiboxximVaccines

Anti-infective market in sub-Saharan Africa set to reach $377 million in 2018


The high incidence of infectious diseases in sub-Saharan Africa is expected to sustain the demand for…

Antibiotics and Infectious diseasesGenericsMarkets & MarketingPharmaceuticalRest of the World

SOBI gains distribution rights for Megace, Monopril, Cefzil and Duricef from PharmaSwiss


Swedish Orphan Biovitrum (STO: SOBI) says that it has entered into a distribution agreement with privately-held…

Antibiotics and Infectious diseasesCardio-vascularCefzilDuricefEuropeLicensingMegaceMonoprilOncologyPharmaceuticalPharmaSwissSobiSwedish Orphan Biovitrum

IMI launches antimicrobial resistance projects to revitalize antibiotic development


Europe's Innovative Medicines Initiative yesterday launched two new projects through its antimicrobial…

Antibiotics and Infectious diseasesEuropePharmaceuticalResearch

NICE "green light" for Novartis' Tobi Podhaler and Forest's Colobreathe


The UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE), in a final draft…

Antibiotics and Infectious diseasesColoBreatheEuropeForest LaboratoriesNovartisPharmaceuticalPricingRare diseasesRegulationTobi Podhaler

Pharmstandard to produce Janssen's anti-TB drugs in Russia; Nyuvak deal


JSC Pharmstandard (PHST: MM), one of Russia's largest pharmaceutical producers, has signed an agreement…

Antibiotics and Infectious diseasesbedaquilineEuropeJanssenJohnson & JohnsonMarkets & MarketingNyuvakOncologyPharmaceuticalPharmstandardProductionquisinostat

New executive director of the Global Fund outlines ambitious agenda


Mark Dybul yesterday took charge as executive director of the Global Fund to Fight AIDS, Tuberculosis…

Anti-viralsAntibiotics and Infectious diseasesFinancialManagementPharmaceuticalTropical diseases

Janssen's TB drug Sirturo gains US FDA approval


The US Food and Drug Administration has granted accelerated approval for US health care major Johnson…

Antibiotics and Infectious diseasesbedaquilineJanssenJohnson & JohnsonNorth AmericaPharmaceuticalRegulationSirturo

Public Citizen urges FDA to reject accelerated approval for Janssen's bedaquiline


The US Food and Drug Administration should not approve the anti-tuberculosis drug bedaquiline from Janssen,…

Antibiotics and Infectious diseasesbedaquilineJohnson & JohnsonNorth AmericaPharmaceuticalRegulation

NeRRe Therapeutics created to develop NRAs from GSK; GlycoVaxyn deal with GSK


NeRRe Therapeutics was launched in the UK yesterday to develop a portfolio of clinical and pre-clinical…

Antibiotics and Infectious diseasesBiotechnologyFinancialGlaxoSmithKlineGlycoVaxynLicensingNeRReTherapeuticsNeurologicalNovo NordiskPharmaceuticalResearchVaccines

AstraZeneca's Brilinta gains Class I in ACCF/AHA Guidelines; enters deal with Progenics


Anglo-Swedish drug major AstraZeneca (LSE: AZN) announced yesterday that a combined panel of experts…

Antibiotics and Infectious diseasesAstraZenecaBrilintaCardio-vascularLicensingMedImmunePharmaceuticalProgenics PharmaceuticalsRegulation

US FDA approvals for Signifor, raxibacumab and Iclusig


In a flurry of activity from the US Food and Drug Administration on Friday, the agency - which looks…

Antibiotics and Infectious diseasesAriad PharmaceuticalsGlaxoSmithKlineIclusigNorth AmericaNovartisOncologyPharmaceuticalRare diseasesraxibacumabRegulationSignifor

India's Macleods Pharma to invest $25 million in production in Russia; Ferring to start manufacturing


Indian drugmaker Macleods plans to invest up to 700 million roubles (around $25 million) in the construction…

Antibiotics and Infectious diseasesEuropeFerring PharmaceuticalsGenericsIzvarino PharmaMacleods PharmaceuticalsOncologyPharmaceuticalProduction

Alfa Wassermann and Norgine get EU approval for Xifaxan


Italy-based Alfa Wassermann and Netherlands-headquartered Norgine say they have received European Marketing…

Alfa WassermannAntibiotics and Infectious diseasesEuropeNorginePharmaceuticalRegulationXifaxan

Major constraints in the hospital-treated infections drug market include generic erosion


The hospital-treated infections (HTI) drug market, the loss of patent protection for key branded products…

Antibiotics and Infectious diseasesGenericsGlobalMarkets & MarketingPharmaceuticalResearch

AstraZeneca inks deal for Optimer's fidaxomicin in Latin America


USA-based Optimer Pharmaceuticals (Nasdaq: OPTR) says it has executed an exclusive agreement with Anglo-Swedish…

Antibiotics and Infectious diseasesAstraZenecafidaxomicinLicensingOptimer PharmaceuticalsPharmaceuticalSouth America

Mixed FDA panel vote for Theravance's Vibativ for nosocomial pneumonia


US drug developer Theravance (Nasdaq: THRX) saw its shares rise more than 5% $22.48 by close of trading…

Antibiotics and Infectious diseasesPharmaceuticalRegulationTheravanceVibativ

126 to 150 of 212 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top